India underinvests in science
Express Pharma|July 2021
Unless we build more than simply two or three global centres of scientific excellence and training, and unless we reward our scientists to work in those institutions, it will be hard for us to compete with countries like China, informs Dr Swami Subramaniam, CEO, Ignite Life Science Foundation to Akanki Sharma in an exclusive interview
Akanki Sharma
India underinvests in science

Give us a brief about Ignite Life Science Foundation - the story of its origin, its goal and target audience, etc.

Ignite was launched formally at an event in January 2020 but its story had begun prior to that. It is the brainchild of Professor Ramaswamy Subramanian, who was at that time heading C-CAMP in Bengaluru - a part of the Bangalore biocluster. During his working years in India, he recognised many problems Indian scientists were facing and it was not simply a matter of quantum of funding; there were multiple factors.

Research productivity thrives in a complex ecosystem. Very few countries in the world have succeeded in building such self-sustaining ecosystems consisting of multiple factors -government funding, academic institutions (that are often private) that consider research an important purpose for their existence, ability to attract the best students from the global pool, private philanthropists willing to support science through large endowments and the co-existence of research universities with communities of investors, start-ups and large company R&D facilities The Boston-Cambridge (Harvard) area and the San Francisco Bay Area (Stanford), Cambridge University (Cambridge, UK) and the Stockholm area (Stockholm University) are some examples.

Building out such ecosystems takes time, but Rams and his scientific peers got together with leading business persons and academics in India to find Ignite as an organisation that would nurture good science using philanthropic money. Connecting uHNIs to science in Indian universities is the first step towards getting widespread acknowledgement of the challenges facing Indian science and pooling resources and capabilities to solve some of these challenges - funding is only one among those.

Bu hikaye Express Pharma dergisinin July 2021 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

Bu hikaye Express Pharma dergisinin July 2021 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

EXPRESS PHARMA DERGISINDEN DAHA FAZLA HIKAYETümünü görüntüle
MAKING SUSTAINABILITY SUSTAINABLE
Express Pharma

MAKING SUSTAINABILITY SUSTAINABLE

Driven by stringent regulations, rising investor expectations, consumer demand, and operational considerations, MSME pharma companies need to carefully balance their sustainability goals with financial viability

time-read
10+ dak  |
September 2024
New energy recovery system for tablet coaters
Express Pharma

New energy recovery system for tablet coaters

Upto 50 per cent less steam energy consumption

time-read
5 dak  |
September 2024
The future of pharma logistics: Trends, challenges, and opportunities
Express Pharma

The future of pharma logistics: Trends, challenges, and opportunities

Nikhil Agarwal, President, CJ Darcl Logistics explains that the future of pharma logistics is a thrilling frontier shaped by technological advancements, regulatory challenges, and the imperative of sustainability. As the industry transforms, logistics providers must embrace innovative solutions and adapt to shifting demands

time-read
3 dak  |
September 2024
Achieving Aatmanirbharta In APIs Are We On The Right Track?
Express Pharma

Achieving Aatmanirbharta In APIs Are We On The Right Track?

As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a key goal for the pharma sector. AatmaNirbharta will be crucial for the sector as it continues to protect the country from the existing and emerging health threats

time-read
9 dak  |
August 2021
Yokogawa launches OpreX Data Model Broker
Express Pharma

Yokogawa launches OpreX Data Model Broker

A plant data transformation platform, OpreX automatically verifies discrepancies and inconsistencies in data to improve efficiency in plant construction and operation

time-read
2 dak  |
August 2021
Understanding the nuances of generics injectables
Express Pharma

Understanding the nuances of generics injectables

At a webinar, explaining the West Pharma's AccelTRA Components Program, industry experts explained why the use of glass vials and stoppers as primary container closure systems (CCS) has become crucial

time-read
6 dak  |
August 2021
Trending in nutraceuticals: Science meets sustainability
Express Pharma

Trending in nutraceuticals: Science meets sustainability

Zeljko Pockaj, Vice President, Global Pharmaceutical Industry, mentions the key trends that are believed to drive innovations and formulations for nutraceuticals’ development around the globe

time-read
3 dak  |
August 2021
The growth of e-pharmacies in India
Express Pharma

The growth of e-pharmacies in India

Rahul Nath Choudhury, Research fellow, ICWA, explains what motivates people in the pharma industry to invest into e-pharmacies, along with various other growth factors associated with these

time-read
4 dak  |
August 2021
Xylitol and Maltitol: Low-calorie sugar alternatives
Express Pharma

Xylitol and Maltitol: Low-calorie sugar alternatives

Polyols like Xylitol and Maltitol offer important health benefits. Unlike general sugar-free sweeteners, these do not have any bitter-after taste

time-read
4 dak  |
August 2021
Single-use TC gaskets and their importance
Express Pharma

Single-use TC gaskets and their importance

Depending on the application, gaskets are manufactured by different types of Material of Construction (MOC) such as Silicone, EPDM, Viton (FKM), Nitrile, Neoprene, PTFE, etc.

time-read
2 dak  |
August 2021